As of 4:00pm ET
| -2.09 / -6.60%|
The 8 analysts offering 12-month price forecasts for Insmed Inc have a median target of 41.50, with a high estimate of 54.00 and a low estimate of 32.00. The median estimate represents a +40.34% increase from the last price of 29.57.
The current consensus among 8 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.